Intergroup 0144 a phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): Mature outcome results and pelvic failure analysis

Stephen R Smalley ,A.b Benson ,C Cripps ,S Williamson ,Jim Martenson ,Jacqueline Benedetti ,B Fisher ,John M Robertson ,Ruth Mayer ,Norman C Estes

doi:10.1016/s0360-3016(04)01097-1

Intergroup 0144 a phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): Mature outcome results and pelvic failure analysis

Stephen R Smalley , A.b Benson + Show 8 more

https://doi.org/10.1016/s0360-3016(04)01097-1

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics	Publication Date: Sep 1, 2004
Citations: 4

Affiliation: Olathe Medical Center, Northwestern University, Ottawa Regional Cancer Foundation, University of Kansas, Mayo Clinic, SWOG Cancer Research Network, Beaumont Hospital, Royal Oak, Dana-Farber Cancer Institute, Illinois College, University of Illinois at Chicago

#Or Overall Survival #Pelvic Failure + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Intergroup 0144 a phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): Mature outcome results and pelvic failure analysis

Full Text